Abstract
Dengue fever is acute febrile diseases, itâ??s caused by one of four closely related virus serotypes of the genusare Flavi virus, family Flaviviridae. Each serotype is sufficiently different that there is no cross-protection and epidemics caused by multiple serotypes can occurs. Itâ??s transmitted to humans by the mosquito. The incidence of dengue has grown around the world in recent a period of ten years. However, several classes of agents are in under investigation as potential anti-dengue drugs, including direct host modulators, antivirals, and RNAi therapeutics. These anti-dengue drugs in development will be reviewed here.
Keywords
Dengue viruses, Aedes mosquito, Treatment
How to Cite:
Jitesh N. Patil , EMERGING THERAPY FOR DENGUE , Volume 8 , Issue 5, may 2022, EPRA International Journal of Multidisciplinary Research (IJMR) ,